Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CONMED CORPORATION

(CNMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
126.61(c) 131.41(c) 134.39(c) 133.3(c) 133.77(c) Last
210 518 320 876 204 132 236 117 182 660 Volume
-1.96% +3.79% +2.27% -0.81% +0.35% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 1 023 M - -
Net income 2021 72,2 M - -
Net Debt 2021 641 M - -
P/E ratio 2021 60,1x
Yield 2021 0,58%
Sales 2022 1 104 M - -
Net income 2022 97,3 M - -
Net Debt 2022 529 M - -
P/E ratio 2022 45,2x
Yield 2022 0,60%
Capitalization 3 892 M 3 892 M -
EV / Sales 2021 4,43x
EV / Sales 2022 4,01x
Nbr of Employees 3 400
Free-Float 92,2%
More Financials
Company
CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery... 
More about the company
Ratings of CONMED Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about CONMED CORPORATION
07/16CONMED CORP : Entry into a Material Definitive Agreement, Creation of a Direct F..
AQ
07/15CONMED : UBS Starts CONMED at Buy With $160 Price Target
MT
07/01CONMED CORPORATION : to Announce Second Quarter 2021 Financial Results on July 2..
BU
06/16INSIDER TRENDS : Conmed Corp Insider Extends 90-Day Selling Trend
MT
06/14CONMED CORPORATION : Ex-dividend day for
FA
06/07CONMED : Insider Selling in Conmed Corp (CNMD) Shares Continues
MT
06/04INSIDER TRENDS : Conmed Corp Insider Extends 90-Day Selling Trend
MT
05/25CONMED : Barclays Starts CONMED at Overweight with $175 Price Target
MT
05/20CONMED CORP : Submission of Matters to a Vote of Security Holders, Other Events ..
AQ
05/19CONMED : Insider Selling at Conmed Corp (CNMD) Continues with Significant Sale
MT
05/19CONMED : Keeps Quarterly Cash Dividend at $0.20 Per Share, Payable July 6 to Sha..
MT
05/19CONMED CORPORATION : Announces Quarterly Cash Dividend
BU
05/19CONMED Corporation Declares Quarterly Cash Dividend, Payable July 6, 2021
CI
05/18INSIDER TRENDS : Conmed Corp Insider Extends 90-Day Selling Trend
MT
05/06INSIDER TRENDS : Insider Sales Add to 90-Day Trend at Conmed Corp
MT
More news
News in other languages on CONMED CORPORATION

- No features available -

More news
Analyst Recommendations on CONMED CORPORATION
More recommendations
Chart CONMED CORPORATION
Duration : Period :
CONMED Corporation Technical Analysis Chart | CNMD | US2074101013 | MarketScreener
Technical analysis trends CONMED CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 133,77 $
Average target price 156,83 $
Spread / Average Target 17,2%
EPS Revisions
Managers and Directors
Curt R. Hartman Chairman, President & Chief Executive Officer
Todd W. Garner Chief Financial Officer & Executive Vice President
Shanna L. Cotti-Osmanski Chief Information Officer & EVP-IT
Mark E. Tryniski Independent Director
Brian P. Concannon Independent Director
Sector and Competitors
1st jan.Capi. (M$)
CONMED CORPORATION19.44%4 102
ABBOTT LABORATORIES10.33%200 283
MEDTRONIC PLC9.73%168 081
BECTON, DICKINSON AND COMPANY0.34%70 145
HOYA CORPORATION3.33%50 251
ALIGN TECHNOLOGY, INC.19.44%48 667